Reply

Affiliations

¹ Robarts Clinical Trials, University of Western Ontario, London, Ontario, Canada; Department of Medicine, Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada.

Comment

Reena Khanna et al. Gastroenterology. 2016 Apr.

. 2016 Apr;150(4):1041-2.

doi: 10.1053/j.gastro.2016.02.057. Epub 2016 Feb 27.

¹ Robarts Clinical Trials, University of Western Ontario, London, Ontario, Canada; Department of Medicine, Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada.

No abstract available

Comment on

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG; REACT Study Investigators. Khanna R, et al. Lancet. 2015 Nov 7;386(10006):1825-34. doi: 10.1016/S0140-6736(15)00068-9. Epub 2015 Sep 3. Lancet. 2015. PMID: 26342731 Clinical Trial.
Early Combined Immunosuppression in Crohn's Disease: Acting Rather Than REACTing.
Peyrin-Biroulet L, Danese S. Peyrin-Biroulet L, et al. Gastroenterology. 2016 Apr;150(4):1040-1. doi: 10.1053/j.gastro.2016.02.056. Epub 2016 Feb 27. Gastroenterology. 2016. PMID: 26922865 No abstract available.